You have 9 free searches left this month | for more free features.

Cholestatic Liver Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cholestatic Liver Disease Trial in Shanghai (Rich medium chain fatty acid milk powder group, Regular milk powder group)

Not yet recruiting
  • Cholestatic Liver Disease
  • Rich medium chain fatty acid milk powder group
  • Regular milk powder group
  • Shanghai, China
    zhaoyang Gou
Jun 26, 2023

Osmotic Fragility in Red Blood Cells of Pediatric Cholestatic

Active, not recruiting
  • Cholestasis
  • Red Cell Membrane and Enzyme Abnormalities
  • ektacytometry of red blood cells
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 12, 2022

Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease Trial in Indianapolis (Saroglitazar Magnesium 1 mg, Saroglitazar

Recruiting
  • Hepatic Impairment
  • +2 more
  • Saroglitazar Magnesium 1 mg
  • Saroglitazar Magnesium 2 mg
  • Indianapolis, Indiana
    Indiana University
Apr 23, 2022

Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester

Recruiting
  • Primary Sclerosing Cholangitis
  • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Feb 22, 2022

    Cholestatic Liver Disease Trial in Worldwide (Maralixibat)

    Active, not recruiting
    • Cholestatic Liver Disease
    • Los Angeles, California
    • +16 more
    Jan 19, 2022

    Alagille Syndrome Trial in Birmingham, Leeds, London (LUM001 (Maralixibat))

    Completed
    • Alagille Syndrome
    • LUM001 (Maralixibat)
    • Birmingham, West Midlands, United Kingdom
    • +2 more
    Nov 17, 2021

    Progressive Familial Intrahepatic Cholestasis, Alagille Syndrome, Cholestatic Liver Disease Trial in Worldwide (Maralixibat)

    Recruiting
    • Progressive Familial Intrahepatic Cholestasis
    • +2 more
    • Los Angeles, California
    • +13 more
    Jul 18, 2022

    Progressive Familial Intrahepatic Cholestasis (PFIC) Trial in Worldwide (LUM001 (Maralixibat))

    Completed
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • LUM001 (Maralixibat)
    • Los Angeles, California
    • +9 more
    Jun 16, 2021

    Alagille Syndrome Trial in Canada, United States (LUM001 (Maralixibat))

    Completed
    • Alagille Syndrome
    • LUM001 (Maralixibat)
    • Los Angeles, California
    • +10 more
    Jun 29, 2021

    Cholestatic Liver Disease Trial in Jakarta Pusat (, probiotics)

    Recruiting
    • Cholestatic Liver Disease
    • placebo
    • probiotics
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Cipto Mangunkusumo Hospital
    Mar 5, 2021

    Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule

    Recruiting
    • Drug-Induced Liver Injury
    • +2 more
    • MT2004 Capsule
    • MT2004 Capsule Placebo
    • Shanghai, Shanghai, China
      Shanghai Jiaotong University School of Medicine,Renji Hospital
    Aug 25, 2023

    Primary Biliary Cholangitis Trial in Birmingham (Home-based exercise program)

    Terminated
    • Primary Biliary Cholangitis
    • Home-based exercise program
    • Birmingham, West Midlands, United Kingdom
      Liver Unit, University Hospital Birminghmam
    Jul 5, 2020

    Pruritus Trial (Linerixibat)

    Available
    • Pruritus
    • (no location specified)
    Jul 1, 2022

    End Stage Liver DIsease Trial (sequential adolesent left lateral lobe liver transplantation (SALT))

    Not yet recruiting
    • End Stage Liver DIsease
    • sequential adolesent left lateral lobe liver transplantation (SALT)
    • (no location specified)
    Oct 3, 2023

    Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body

    Recruiting
    • Liver Cirrhosis
    • +2 more
    • Handgrip strength test
    • +2 more
    • Roma, RM, Italy
      CEMAD
    Oct 20, 2023

    Liver Fat Content and Bariatric Surgery

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • +2 more
    • We do not have any intervention type
    • Qingdao, Shandong, China
      Qingdao University Affiliated Hospital
    Sep 29, 2023

    Non-Alcoholic Fatty Liver Disease Trial (Standard Soy Milk, 2% Fat Cow's Milk)

    Not yet recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Standard Soy Milk
    • 2% Fat Cow's Milk
    • (no location specified)
    Nov 9, 2023

    Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

    Not yet recruiting
    • Fatty Liver, Nonalcoholic
    • SGLT2 inhibitor
    • (no location specified)
    Oct 31, 2023

    Type 2 Diabetes, Non Alcholic Fatty Liver Disease Trial (Bempedoic acid)

    Not yet recruiting
    • Type 2 Diabetes
    • Non Alcholic Fatty Liver Disease
    • Bempedoic acid
    • (no location specified)
    Sep 14, 2023

    Patients With End Stage Liver Disease

    Not yet recruiting
    • Liver Cirrhosis
    • +6 more
      • Palo Alto, California
        Stanford Hospital
      Aug 23, 2023

      Liver Cirrhosis Trial in New Delhi (EUS guided liver biopsy, Percutaneous Liver Biopsy)

      Not yet recruiting
      • Liver Cirrhosis
      • EUS guided liver biopsy
      • Percutaneous Liver Biopsy
      • New Delhi, India
        Institiute of liver and biliary sciences
      Sep 20, 2023

      Non-alcoholic Fatty Liver Disease in Low Birth Weight

      Not yet recruiting
      • Non-Alcoholic Fatty Liver Disease
      • Low Birth Weight
        • (no location specified)
        Jun 6, 2023

        Accurate Point of Care Liver Disease Diagnostics

        Recruiting
        • NAFLD
        • Nonalcoholic Fatty Liver
        • Liverscope® exam
        • +5 more
        • La Jolla, California
          University of California San Diego
        Aug 8, 2023

        Non-Alcoholic Fatty Liver Disease Trial (Field-cycling imaging (FCI))

        Not yet recruiting
        • Non-Alcoholic Fatty Liver Disease
        • Field-cycling imaging (FCI)
        • (no location specified)
        Apr 21, 2023

        Transient Elastograghy to Detect Non Alcoholic Fatty Liver

        Not yet recruiting
        • Non-Alcoholic Fatty Liver Disease
        • Renal Transplant Complication Pre-Existing Disease
        • transient elastograghy
        • (no location specified)
        May 30, 2023